U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
153451153451Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma PatientsActive, not recruitingNo Results AvailableMultiple Myeloma|Newly Diagnosed PatientsDrug: Melphalan|Drug: Lenalidomide|Drug: Prednisone|Drug: Melphalanhttps://ClinicalTrials.gov/show/NCT00551928
153452153452A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)CompletedNo Results AvailableBacterial Infections; Virus DiseasesBiological: AR51 (12, 10)|Biological: PR51 (3, 10)|Biological: PR51 (6, 10)|Biological: PENTACELâ„¢|Biological: RECOMBIVAX HBâ„¢https://ClinicalTrials.gov/show/NCT00551915
153453153453Effect of an Anterior Chamber Infusion System on Trabeculectomy OutcomesWithdrawnNo Results AvailableGlaucomaProcedure: Trabeculectomy with anterior chamber infusion system|Procedure: Trabeculectomy without anterior chamber infusion systemhttps://ClinicalTrials.gov/show/NCT00551902
153454153454Cyclophosphamide and Celecoxib in Treating Patients With Advanced CancerCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: celecoxib|Drug: cyclophosphamide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00551889
153455153455Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: MK0653, ezetimibe / Duration of Treatment: 30 Weeks|Drug: Comparator : ezetimibe (+) simvastatin / Duration of Treatment: 30 Weekshttps://ClinicalTrials.gov/show/NCT00551876
153456153456Developing Violence Prevention Therapy for Substance AbusersCompletedNo Results AvailableSubstance Use Disorders|ViolenceBehavioral: IVPThttps://ClinicalTrials.gov/show/NCT00551863
153457153457A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor PatientsCompletedNo Results AvailableAdvanced Cancer|Refractory CancerDrug: AV-412https://ClinicalTrials.gov/show/NCT00551850
153458153458Immune Response to Influenza VaccinationCompletedNo Results AvailableSolid Organ Transplantation|Chronic Kidney Diseasehttps://ClinicalTrials.gov/show/NCT00551837
153459153459Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in ChildrenRecruitingNo Results AvailableEsophageal Stricture|Caustic Esophageal Stricture|Peptic Esophageal Stricture|Post-Surgical Esophageal StrictureDrug: Mitomycin Chttps://ClinicalTrials.gov/show/NCT00551824
153460153460Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone.CompletedNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)|Cystic FibrosisDrug: SB-656933-AAAhttps://ClinicalTrials.gov/show/NCT00551811
153461153461Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High GradeCompletedNo Results AvailableHodgkin's Disease|Malignant Lymphomas High Grade|ChemoresistanceProcedure: TEP au MIBIhttps://ClinicalTrials.gov/show/NCT00551798
153462153462Surveillance Study of Women Taking Intrinsa®TerminatedNo Results AvailableOvariectomy|Hysterectomy|Hypoactive Sexual Desire Disorderhttps://ClinicalTrials.gov/show/NCT00551785
153463153463A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.CompletedNo Results AvailableAlzheimer's DiseaseDrug: SB-742457https://ClinicalTrials.gov/show/NCT00551772
153464153464Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedHas ResultsEsophageal CancerDrug: 5-Fluorouracil|Drug: Oxaliplatin|Drug: Cetuximab|Drug: Docetaxel|Procedure: Surgery|Radiation: Radiotherapyhttps://ClinicalTrials.gov/show/NCT00551759
153465153465The Purple Grape Juice StudyCompletedHas ResultsCardiovascular DiseaseDietary Supplement: Purple Grape Juicehttps://ClinicalTrials.gov/show/NCT00551746
153466153466Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerRecruitingNo Results AvailableLung CancerDrug: carboplatin|Drug: paclitaxel|Drug: paclitaxel poliglumexhttps://ClinicalTrials.gov/show/NCT00551733
153467153467Motivation and Patch Treatment for HIV-Positive SmokersCompletedNo Results AvailableHIV Infections|Smoking CessationBehavioral: Standard Care|Behavioral: Motivational Enhancementhttps://ClinicalTrials.gov/show/NCT00551720
153468153468Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisDrug: CRx-102 (2.7/180)|Drug: prednisolone|Drug: dipyridamole|Drug: placebo|Drug: CRx-102 (2.7/360)https://ClinicalTrials.gov/show/NCT00551707
153469153469A Second Study to Determine the Effect of GSK256073A on HVTsCompletedNo Results AvailableHealthy Subjects|DyslipidaemiasDrug: GSK256073A tabletshttps://ClinicalTrials.gov/show/NCT00551694
153470153470Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart FailureRecruitingNo Results AvailableLeft Ventricular Dysfunction|Heart FailureDevice: biventricular pacemaker with epicardial left ventricular lead|Device: transvenous left ventricular lead placementhttps://ClinicalTrials.gov/show/NCT00551681
153471153471A Prospective, Randomized Study of Operative and Nonoperative Treatment for Primary Traumatic Patellar DislocationCompletedNo Results AvailablePatellar DislocationProcedure: proximal patellar surgery|Procedure: Nonoperativehttps://ClinicalTrials.gov/show/NCT00551668
153472153472Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected PatientsCompletedNo Results AvailableHuman Immunodeficiency Viruses|Kidney Failure|HIV Infectionshttps://ClinicalTrials.gov/show/NCT00551655
153473153473Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature BabiesActive, not recruitingHas ResultsLung DiseaseDrug: Nitric Oxide for inhalation|Drug: Nitrogenhttps://ClinicalTrials.gov/show/NCT00551642
153474153474A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)CompletedNo Results AvailableBacterial Infections; Virus DiseasesBiological: AR51 (12, 10)|Biological: PR51 (3, 10)|Biological: PR51 (6, 10)|Biological: PR51 (6, 15)https://ClinicalTrials.gov/show/NCT00551629
153475153475Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency ContraceptionCompletedNo Results AvailableContraceptionDrug: CDB-2914|Drug: Levonorgestrelhttps://ClinicalTrials.gov/show/NCT00551616
153476153476Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents SchedulesCompletedNo Results AvailableBio-Equivalency of 2 Treatment Schedules in HD PatientsDrug: switch (epoetinum beta, darbepoetinum)|Drug: continuation (darbepoetinum)https://ClinicalTrials.gov/show/NCT00551603
153477153477Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Placebo tablet|Drug: Sitagliptin tablet|Drug: Saline infusion|Drug: Exendin(9-39) infusionhttps://ClinicalTrials.gov/show/NCT00551590
153478153478Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical TrialRecruitingNo Results AvailableOvarian NeoplasmsProcedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)|Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)https://ClinicalTrials.gov/show/NCT00551577
153479153479Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone MaleateCompletedNo Results AvailableHealthy Subjects|Obesity|Type 2 Diabetes MellitusDrug: rosiglitazone maleatehttps://ClinicalTrials.gov/show/NCT00551564
153480153480Prenatal Pelvic Floor Prevention (3PN)CompletedNo Results AvailableUrinary Incontinence|Anal Incontinence|Genital ProlapseOther: Pelvic floor muscle training with physiotherapist|Other: Written information about kegel exerciseshttps://ClinicalTrials.gov/show/NCT00551551

* Görseller ve İçerik tekif hakkına sahip olabilir